Periodic Reporting for period 2 - SER (Sensory Endovascular Robot)
Berichtszeitraum: 2023-05-01 bis 2024-07-31
The Sentante system was successfully validated in number of pre-clinical tests (cadaver tests, animal tests, GLP animal study) as well as first in human clinical trial. The system will receive CE mark after the project and will be commercialized in the EU and the US markets.
New patent applications were submitted to protect relevant IP.
Sentante does not change clinical workflow or instruments used in the procedure. It just enables remote work for the doctor. While working remotely, doctors work the same way they are trained to - the interface with the robot is via the same instruments as in a manual procedure and haptic force feedback allows to feel the catheter and guidewire resistance just as if they would work manually next to a patient.
Sentante robotic system transforms the way endovascular procedures are performed - it allows performance of the entire endovascular procedure remotely:
- Enabling telemedicine and 24/7 coverage;
- Improving hospital efficiency (cost optimisation, specialisation, digitisation);
- Improving the procedure (increasing accuracy and precision, reducing medical error):
- Empowering physicians - superb control of the procedure with haptic feedback and new functionalities;
- Providing an ergonomic, remote workplace without x-ray exposure to medical personnel.